Mark Woyshville, MD
Enriched profileCEO and Medical Director · North Star Medical Research
Mark Woyshville is CEO and Medical Director at North Star Medical Research. OpenAlex indexes 13 publications with 1,007 citations (h-index 11); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 3 Nov 2026
Overview
Updated 5 Nov 2026
Mark Woyshville, MD, is CEO and Medical Director at North Star Medical Research, LLC. The public record shows 13 publications with 1,007 citations (h-index 11), centered on Psychiatry. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 31 companies.
- Top research focus: Psychiatry
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 31 companies
Generated from the cited public record · current as of 5 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →stamfordadvocate.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cms.gov ↗
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
18660 Bagley Rd. Building Ii Suite 205, Middleburg Heights, OH 44130
Clinical trials
Updated 5 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression
Sponsor: CeNeRx BioPharma Inc.
Industry payments
Updated 5 Nov 2026
31 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)Program year202517 payments$14,455openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year202517 payments$10,354openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20253 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Online presence
Updated 5 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/mark-woyshville-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 5 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →care.healthline.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cleveland.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Charles Nemeroff, MD
Dell Medical School
Dennis Charney, MD
Icahn School of Medicine at Mount Sinai
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University